Warner Chilcott UK Limited

1 The Heights, Brooklands, Weybridge, KT12 0NY
Telephone: +44 (0)1932 82 9600
Fax: +44 (0)1932 82 1644
WWW: http://www.wcrx.com
Medical Information Direct Line: +44 (0)800 0328 701
Medical Information e-mail: medcomukir@wcrx.com
Medical Information Fax: +44 (0)1932 824 775

Patient Information Leaflet last updated on the eMC: 03/11/2011
PIL Didronel PMO

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
Updated on 27/10/2011 and displayed until 03/11/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/07/2010 and displayed until 27/10/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 07/07/2010 and displayed until 28/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 03/11/2008 and displayed until 07/07/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 25/10/2006 and displayed until 03/11/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/08/2003 and displayed until 25/10/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 14/05/2003 and displayed until 01/08/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 18/07/2000 and displayed until 14/05/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   calcium carbonate
   etidronate disodium